# A Study of LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis

> **NCT07660614** · PHASE1,PHASE2 · RECRUITING · sponsor: **Leal Therapeutics, Inc** · enrollment: 56 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** LTX-002
- **OTHER:** Placebo (aCSF)

## Key facts

- **NCT ID:** NCT07660614
- **Lead sponsor:** Leal Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-29
- **Primary completion:** 2031-06
- **Final completion:** 2031-06
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07660614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07660614, "A Study of LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07660614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*